COMMUNIQUÉS West-GlobeNewswire

Advanced Proteome Therapeutics Advances its Technological Capability
18/06/2018
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8), is pleased to report continuing progress on its efforts to develop [...]
Arbutus Biopharma to Present at First Annual Roivant Pipeline Day
18/06/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., June 18, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced [...]
Axovant to Present at First Annual Roivant Pipeline Day
18/06/2018
BASEL, Switzerland, June 18, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the first annual Roivant [...]
MediPharm Labs Commences Construction of World-Class Extraction Facility in Australia
18/06/2018
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. WONTHAGGI-VICTORIA, Australia [...]
Nuvus Gro (NUVG) Introduces the New grow.droid Enterprise Grow Factory – Complete Plug & Play Grow Units - Grow up to 1,300 Plants & 1,000 Clones – Revenues up to $6M/Year
18/06/2018
Saint Petersburg, FL, June 18, 2018 (GLOBE NEWSWIRE) -- Nuvus Gro Corp. (OTC PINK: NUVG), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]
Burcon’s Peazazz and Peazac Pea Proteins Receive Self-Affirmed GRAS Status
18/06/2018
GRAS Notification Submitted to US FDA VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX:BU) (“Burcon” or the “Company”) a leader in natural product extraction, [...]
GPS SmartSole® Used to Predict Wandering of Individuals with Dementia
18/06/2018
George Mason University’s College of Health and Human Services Completes Phase II of Machine Learning Wandering Prediction Research LOS ANGELES, June 18, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform [...]
Cognition Therapeutics Initiates NIA-Funded SPARC Study of Elayta™ to Assess Changes in Synaptic Density and Cognitive Performance in Alzheimer's Disease
18/06/2018
First Longitudinal Study of Novel Synaptic Imaging Agent at Yale Alzheimer's Disease Research Unit and Yale PET Center Pittsburgh, June 18, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics , Inc. , a clinical stage [...]
Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research
18/06/2018
Press Release 18 June 2018 Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research Immunicum AB (publ; IMMU.ST) announced today the online publication of a [...]
Evolus Expands Management Team with Appointment of Michael Mazen Jafar as Chief Marketing Officer
18/06/2018
Mr. Jafar Joins Evolus from Allergan as the Company Expands its Commercial Infrastructure IRVINE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus” or the “Company”), a company dedicated to [...]
Tetra Bio-Pharma Takes on Fentanyl in Head to Head Trial for the Treatment of Breakthrough Pain
18/06/2018
First Clinical Study to Assess Cannabis as an Alternative to Fentanyl ORLEANS, Ontario, June 18, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE [...]
PolarityTE Provides Corporate Update on Company Progress
18/06/2018
SALT LAKE CITY, June 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]
IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2018
18/06/2018
MONTRÉAL, June 18, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the nine months ended April 30, 2018. “We are pleased to see the [...]
Exalenz Announces Confidential Submission of Draft Registration Statement for Initial Public Offering
18/06/2018
MODI’IN, Israel and MANASQUAN, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]
Allan R. Mendez, DPT, SCS is Selected to the American Health Council’s Physical Therapy Board
18/06/2018
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Allan R. Mendez, DPT, SCS to its Board of Physical Therapy for his outstanding contributions to improving his patients’ health and well- [...]
Everett Jolly, Host of “Stock Day” Welcomes Richard T. Schumacher of Pressure BioSciences Back on the Show to Discuss Significant Debt to Equity Conversions and other Recent Accomplishments
18/06/2018
PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” and “the Company”) was recently interviewed on Uptick Newswire’s “Stock Day” podcast [...]
Caelum Biosciences Announces Presentation of Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis at American Society of Echocardiography 29th Annual Scientific Sessions
18/06/2018
Columbia University to present data demonstrating CAEL-101 positively impacts myocardial function in patients with AL amyloidosis as measured by global longitudinal strain NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- [...]
TG Therapeutics, Inc. Presents Phase 2 Data Evaluating Umbralisib in CLL Patients Intolerant to Prior BTK or PI3K Delta Inhibitor Therapy at the 23rd Congress of the European Hematology Association (EHA)
18/06/2018
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced an oral presentation of clinical data from its ongoing Phase 2 study evaluating umbralisib (TGR-1202), the Company’s PI3K [...]
Eloxx Appoints Global Pharmaceutical Leader, Neil Belloff, Executive Vice President, General Counsel and Corporate Secretary
18/06/2018
WALTHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat [...]

Pages